These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32142087)

  • 21. A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.
    Fitzgerald KA; Malhotra M; Gooding M; Sallas F; Evans JC; Darcy R; O'Driscoll CM
    Int J Pharm; 2016 Feb; 499(1-2):131-145. PubMed ID: 26721726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photocontrolled reversible supramolecular assemblies of an azobenzene-containing surfactant with alpha-cyclodextrin.
    Wang Y; Ma N; Wang Z; Zhang X
    Angew Chem Int Ed Engl; 2007; 46(16):2823-6. PubMed ID: 17348049
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis.
    Gooding M; Malhotra M; McCarthy DJ; Godinho BM; Cryan JF; Darcy R; O'Driscoll CM
    Eur J Pharm Sci; 2015 Apr; 71():80-92. PubMed ID: 25703259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lanthanide-integrated supramolecular polymeric nanoassembly with multiple regulation characteristics for multidrug-resistant cancer therapy.
    Jin W; Wang Q; Wu M; Li Y; Tang G; Ping Y; Chu PK
    Biomaterials; 2017 Jun; 129():83-97. PubMed ID: 28329693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates.
    Ohyama A; Higashi T; Motoyama K; Arima H
    Bioconjug Chem; 2016 Mar; 27(3):521-32. PubMed ID: 26715308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple, noninvasive and efficient method for transdermal delivery of siRNA.
    Lin CM; Huang K; Zeng Y; Chen XC; Wang S; Li Y
    Arch Dermatol Res; 2012 Mar; 304(2):139-44. PubMed ID: 22009459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy.
    Qiu C; Wei W; Sun J; Zhang HT; Ding JS; Wang JC; Zhang Q
    Nanoscale; 2016 Jul; 8(26):13033-44. PubMed ID: 27314204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ternary complexes of folate-PEG-appended dendrimer (G4)/α-cyclodextrin conjugate, siRNA and low-molecular-weight polysaccharide sacran as a novel tumor-selective siRNA delivery system.
    Ohyama A; Higashi T; Motoyama K; Arima H
    Int J Biol Macromol; 2017 Jun; 99():21-28. PubMed ID: 28223132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic acid conjugated β-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery.
    Yin H; Zhao F; Zhang D; Li J
    Int J Pharm; 2015 Apr; 483(1-2):169-79. PubMed ID: 25681725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyspermine imidazole-4,5-imine, a chemically dynamic and biologically responsive carrier system for intracellular delivery of siRNA.
    Duan S; Yuan W; Wu F; Jin T
    Angew Chem Int Ed Engl; 2012 Aug; 51(32):7938-41. PubMed ID: 22807030
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)/α-Cyclodextrin Conjugate as an NF-κB siRNA Carrier for the Treatment of Fulminant Hepatitis.
    Motoyama K; Mitsuyasu R; Akao C; Abu Hashim II; Sato N; Tanaka T; Higashi T; Arima H
    Mol Pharm; 2015 Sep; 12(9):3129-36. PubMed ID: 26270769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronic acid-fabricated nanogold delivery of the inhibitor of apoptosis protein-2 siRNAs inhibits benzo[a]pyrene-induced oncogenic properties of lung cancer A549 cells.
    Lin CM; Kao WC; Yeh CA; Chen HJ; Lin SZ; Hsieh HH; Sun WS; Chang CH; Hung HS
    Nanotechnology; 2015 Mar; 26(10):105101. PubMed ID: 25693888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
    Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
    Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy.
    Wu M; Liu X; Jin W; Li Y; Li Y; Hu Q; Chu PK; Tang G; Ping Y
    J Control Release; 2017 May; 253():110-121. PubMed ID: 28302581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronic acid modification of RNase A and its intracellular delivery using lipid-like nanoparticles.
    Wang X; Li Y; Li Q; Neufeld CI; Pouli D; Sun S; Yang L; Deng P; Wang M; Georgakoudi I; Tang S; Xu Q
    J Control Release; 2017 Oct; 263():39-45. PubMed ID: 28153764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
    Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
    Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing effects of galactosylated dendrimer/alpha-cyclodextrin conjugates on gene transfer efficiency.
    Wada K; Arima H; Tsutsumi T; Hirayama F; Uekama K
    Biol Pharm Bull; 2005 Mar; 28(3):500-5. PubMed ID: 15744077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supramolecular Organization and siRNA Binding of Hyaluronic Acid-Coated Lipoplexes for Targeted Delivery to the CD44 Receptor.
    Nascimento TL; Hillaireau H; Noiray M; Bourgaux C; Arpicco S; Pehau-Arnaudet G; Taverna M; Cosco D; Tsapis N; Fattal E
    Langmuir; 2015 Oct; 31(41):11186-94. PubMed ID: 26375384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-Assembled Cationic β-Cyclodextrin Nanostructures for siRNA Delivery.
    Singh RP; Hidalgo T; Cazade PA; Darcy R; Cronin MF; Dorin I; O'Driscoll CM; Thompson D
    Mol Pharm; 2019 Mar; 16(3):1358-1366. PubMed ID: 30721074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.